BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank93
3Y CAGR+29.2%
5Y CAGR+46.9%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+29.2%/yr
Annual compound
5Y CAGR
+46.9%/yr
Recent deceleration
Percentile
P93
Near historical high
vs 5Y Ago
6.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$572.94M-11.9%
2024$650.53M+112.1%
2023$306.77M+15.6%
2022$265.36M+459.4%
2021$47.43M-43.3%
2020$83.66M+162.1%
2019$31.92M+1047.1%
2018$-3.37M-103.7%
2017$90.97M+113.0%
2016$-698.01M-